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Saimiriine herpesvirus 2 (Herpesvirus saimiri) is capable of inducing lethal T-cell lymphoproliferative diseases in primates
and of immortalizing human T lymphocytes in vitro. Two viral oncoproteins, Tip and StpC, are essential for T-cell transfor-
mation by Herpesvirus saimiri strains of the subgroup C, which exhibits a higher transformation potential than other
subgroups of this virus. Despite the importance of these proteins, the molecular basis of their effects on T cells is poorly
understood. It remains unclear how Tip and StpC affect gene expression and what is the molecular basis of their cooperation.
To address these issues, we expressed Tip and StpC in T lymphoblastoid cells and assessed both their effects on and
transcription factors involved in IL-2 gene expression. Our study shows that Tip and StpC cooperate to upregulate IL-2 gene
expression, that their effect is mediated primarily by NF-kB and NF-AT, which is partially dependent on tyrosine phosphor-
ylation. © 2001 Academic Press
Key Words: Herpesvirus saimiri; Tip; StpC; protein tyrosine kinases; interleukin-2; transcription; NF-kB; NF-AT.
t
e
m
1
a
r
o
k
a
(INTRODUCTION
Herpesvirus saimiri is capable of inducing lethal T-cell
lymphoproliferative diseases in primates and of immortal-
izing human T lymphocytes in vitro (reviewed in Broker and
Fickenscher, 1999; Meinl et al., 1995; Trimble and Desro-
siers, 1991; Tsygankov and Romano, 1999). T cells immor-
talized by H. saimiri demonstrate a typical activated pheno-
type, functional biological responses including proliferation
and cytokine production, interleukin-2 (IL-2) dependence,
and antigen specificity (Berend et al., 1993; Biesinger et al.,
1992; Broker et al., 1993; De Carli et al., 1993; Medveczky
and Medveczky, 1989; Mittrucker et al., 1992; Weber et al.,
1993). These functional characteristics make transforma-
tion of T cells by H. saimiri a unique experimental tool for
studying T-cell malignancies and for obtaining large num-
bers of immortalized antigen-specific T cells.
Two open reading frames (ORFs)2 are essential for T-cell
transformation by H. saimiri strains of the subgroup C
(Duboise et al., 1998; Medveczky et al., 1993), which exhibits
a much higher transformation potential than do the other H.
saimiri subgroups (Biesinger et al., 1992; Desrosiers et al.,
1 To whom correspondence and reprint requests should be ad-
ressed at Temple University School of Medicine, Department of Mi-
robiology and Immunology, 3400 N. Broad Street, Kresge Bldg.,
m. 506, Philadelphia, PA 19140. Fax: (215) 707-5205. E-mail:
sygan@astro.temple.edu.
2 Abbreviations used: EMSA, electrophoretic mobility shift assay;
IL-2, interleukin-2; kDa, kilodaltons; MAb, monoclonal antibody; MSCV,
murine stem cell virus; ORF, open reading frame; PTK, protein tyrosine
kinase; TCR, T-cell antigen receptor; TRAF, tumor necrosis factor re-
ceptor-associated factor.
3251986; Medveczky et al., 1989). One of these ORFs encodes
StpC, a protein capable of transforming fibroblasts in vitro
(Jung et al., 1991) and causing multiple epithelial, but not
lymphoid, tumors in transgenic mice (Murphy et al., 1994).
StpC has been shown to bind to Ras in T cells and fibro-
blasts and to activate Ras in fibroblasts (Jung and Desro-
siers, 1995). A recently published report indicates that StpC
binds to tumor necrosis factor receptor-associated factors
(TRAFs) and modestly activates NF-kB when overex-
pressed in epithelial cells. This study also shows that a
mutant form of StpC incapable of binding to TRAF2 or
activating NF-kB cannot support transformation of fibro-
blasts and human T cells (Lee et al., 1999). However, the
connection between the ability of StpC to activate NF-kB in
epithelial cells and the transformation potential of StpC in
fibroblasts is not clear, since some forms of StpC activate
NF-kB, while not transforming fibroblasts, and vice versa
(Jung and Desrosiers, 1995; Lee et al., 1999). Furthermore,
he role of StpC interactions with Ras and TRAFs in the
ffects of StpC on T cells is insufficiently understood.
Unlike stpC, the second ORF essential for T-cell im-
ortalization cannot transform fibroblasts (Jung et al.,
991). The translation product of this ORF, Tip, binds to
nd is phosphorylated by Lck, an Src-family protein ty-
osine kinase (PTK) (Biesinger et al., 1995). It was previ-
usly shown in several experimental systems that the
inase activity of Lck is increased when this PTK inter-
cts with Tip in vitro or in cells overexpressing Tip
Hartley et al., 1999; Lund et al., 1997b; Wiese et al., 1996).
Furthermore, Lck was shown to be associated with ty-
rosine-phosphorylated transcription factors Stat1 and
Stat3 in the lysates of Tip-positive, but not Tip-negative,
0042-6822/01 $35.00
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326 MERLO AND TSYGANKOVT cells (Lund et al., 1997a,b). Recent reports demonstrate
hat Tip is capable of upregulating Stat-dependent tran-
cription in Jurkat cells (Hartley and Cooper, 2000). How-
ver, downregulation of Lck expression and kinase ac-
ivity was shown in Jurkat-based cell lines expressing Tip
s a result of retroviral transduction (Guo et al., 1997;
ung et al., 1995). This downregulation might be ex-
lained by the existence of a negative feedback mech-
nism in Jurkat cells, which prevents hyperactivation of
ck caused by Tip, to keep the activity of this important
egulatory PTK under control.
Taken together, the results described herein suggest
hat Tip and StpC, proteins essential for H. saimiri-in-
duced transformation, exert their effects on cells through
interactions with cellular regulatory mechanisms. How-
ever, despite substantial advances in understanding the
molecular basis of the effects of Tip and StpC, several
important issues related to the mechanisms of these
effects have not yet been addressed. It remains to be
determined whether Tip can regulate transcription fac-
tors other than Stat. Furthermore, it remains unclear
whether Tip and StpC cooperate at the level of transcrip-
tional regulation, as they do in T-cell transformation
(Duboise et al., 1998; Medveczky et al., 1993). Finally,
contribution of protein tyrosine phosphorylation to the
effects of Tip and StpC is poorly understood. To address
these issues, we expressed Tip and StpC in T lympho-
blastoid cells and assessed their effects on lymphokine
gene expression and transcription factor activity in these
cells and the role of protein tyrosine phosphorylation in
these effects. We focused our study on IL-2 gene expres-
sion and transcription factors involved therein, because
an increase in IL-2 production appears to play a signifi-
cant role in the autocrine growth of H. saimiri-trans-
ormed T cells (Broker et al., 1993, 1994; De Carli et al.,
993; Mittrucker et al., 1992, 1993). Since protein tyrosine
hosphorylation is crucial for the regulation of gene
xpression, we also examined protein tyrosine phos-
horylation in Tip- and/or StpC-expressing cells, as well
s the effects of protein tyrosine phosphorylation on IL-2
ene expression and transcription factor activity. This
tudy indicates that Tip and StpC significantly upregulate
L-2 gene expression in lymphoblastoid T cells in re-
ponse to extracellular stimulation. This effect requires
imultaneous expression of Tip and StpC, appears to be
ediated primarily by the NF-kB and NF-AT transcription
factors, and is, at least partially, dependent on protein
tyrosine phosphorylation.
RESULTS
Tip and StpC facilitate, in a synergistic and protein
tyrosine phosphorylation-dependent fashion, IL-2
gene expression in lymphoblastoid T cellsOne major consequence of H. saimiri-induced trans-
formation of T cells is a significant increase in both
t
cconstitutive and inducible expression of multiple cyto-
kines, including IL-2 and interferon-g (Broker et al., 1993,
1994; De Carli et al., 1993; Mittrucker et al., 1992, 1993;
eber et al., 1993). We focused our study on IL-2 gene
xpression because production of IL-2 appears to sig-
ificantly promote growth of H. saimiri-transformed T
cells in culture (Broker et al., 1994; De Carli et al., 1993;
ittrucker et al., 1992, 1993). Furthermore, signaling
pathways and transcription factors involved in the regu-
lation of IL-2 gene are well characterized and therefore
represent a convenient system for mapping possible
mechanistic links between H. saimiri proteins and T-cell
responses. To detect IL-2 gene expression we employed
several complementary approaches.
First, we analyzed the effects of Tip and StpC on IL-2
secretion by MOLT4 cells transduced with Tip and/or
StpC cDNA. The cells were stimulated using various
MAbs against cell surface receptors, as well as PMA and
ionomycin, and the levels of IL-2 in cellular supernatants
were measured. The results of these experiments dem-
onstrate that anti-receptor MAbs, including those to CD3,
CD2, CD4, and CD28, failed to stimulate IL-2 production
by MOLT4 cells (data not shown). Since this failure was
consistent with low densities of CD3, CD2, and CD28 on
the surface of MOLT4 cell lines (data not shown), we
decided to use stimulation with PMA and ionomycin to
further examine the effects of Tip and StpC on these
cells. This stimulation revealed a dramatic effect of Tip
and StpC on IL-2 production by MOLT4 cells. While
Tip2StpC2, Tip1StpC2, or Tip2StpC1 MOLT4 cells
showed no IL-2 secretion either in the presence or in the
absence of PMA and ionomycin, Tip1StpC1 MOLT4 cells
produced substantial amounts of IL-2 in response to a
mixture of PMA and ionomycin (Fig. 1).
Further analysis indicated that, despite the apparent
lack of IL-2 secretion (see Fig. 1), control MOLT4 cells
were capable of producing IL-2 at low levels; when
supernatants were collected at 48 h after stimulation
instead of typical 12 h, IL-2 was detected in the super-
natants of control cells stimulated with PMA and iono-
mycin at approximately 100 pg/ml (data not shown). How-
ever, considering that IL-2 production by control MOLT4
cells was at least 50-fold lower than that by Tip1StpC1
cells, and that prolonged incubations were detrimental
for cell viability (data not shown), we chose to collect
supernatants in all further experiments at 12 h poststimu-
lation.
To rule out the possibility that the observed effects
were caused by clonal variations unrelated to Tip and
StpC expression, we examined several stable clones of
each cell type studied. None of the Tip2StpC2,
Tip1StpC2, or Tip2StpC1 clones studied in these exper-
ments secreted a detectable level of IL-2 in the pres-
nce or in the absence of PMA and ionomycin. By con-
1 1rast, each of the three Tip StpC clones studied se-
reted a substantial amount of IL-2 (Fig. 1).
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327Tip AND StpC STIMULATE TRANSCRIPTIONTo further characterize the mechanisms by which Tip
and StpC upregulated IL-2 production by MOLT4 cells,
we assessed the IL-2 mRNA levels in these cells using
quantitative RT-PCR in the presence of a competitor, or
MIMIC, fragment. MIMICs competed with the DNAs of
interest for specific primers acting as internal standards
in PCR reactions, allowing us to measure the concentra-
tions of these cDNAs. The amount of IL-2 cDNA was
normalized to the amount of b-actin cDNA, and the molar
ratios of the IL-2 cDNA to the b-actin cDNA were deter-
ined for each sample. These experiments demon-
trated that IL-2 mRNA levels in MOLT4 cells expressing
o Tip or StpC, or either Tip or StpC alone, were unde-
ectable regardless of stimulation (Fig. 2). By contrast,
ip1StpC1 MOLT4 cells exhibited a significant increase
in their IL-2 mRNA level in response to PMA and iono-
FIG. 1. Effects of Tip and StpC on IL-2 secretion by MOLT4 cells.
MOLT4 cells were stimulated with PMA and ionomycin where indi-
cated, and their supernatants were analyzed for IL-2 using sandwich
ELISA. Cells expressed Tip and/or StpC, as indicated at the bottom of
the figure. The numbers indicate individual clones of each type. Trip-
licate measurements were performed in each experiment. Means and
SD are shown for one representative experiment from a total of four
experiments.
FIG. 2. Effects of Tip and StpC on IL-2 mRNA levels in MOLT4 cel
arvested, and used for RNA preparation. Quantitative DNA amplificati
ip and/or StpC, as indicated at the figure. Concentrations of MIMIC f
panel. The positions of target cDNAs and MIMICs are indicated by arro
by a twofold titration to more precisely measure the amount of specific cDN
transcripts were calculated. One representative experiment from a total of fivmycin (Fig. 2). None of the Tip2StpC2, Tip1StpC2, or
Tip2StpC1 clones examined in these experiments dem-
onstrated a detectable level of IL-2 mRNA in the pres-
ence or in the absence of PMA and ionomycin, whereas
each of the three Tip1StpC1 clones studied showed a
profound increase in the amount of IL-2 mRNA, reaching
approximately 0.1 of the b-actin mRNA level (data not
shown). Therefore, the effects of Tip and StpC on the
level of IL-2 mRNA in MOLT4 cells correlated well with
their effects on IL-2 secretion by these cells (see Fig. 1),
indicating that Tip and StpC facilitated IL-2 production at
the level of IL-2 mRNA.
Previous findings indicating the crucial role of protein
tyrosine phosphorylation in IL-2 gene expression (re-
viewed in DeFranco, 1995; Howe and Weiss, 1995; Sefton
and Taddie, 1994; Zenner et al., 1995), as well as the
bility of Tip to facilitate protein tyrosine phosphorylation
n T cells (Lund et al., 1997b; Wiese et al., 1996),
rompted us to assess the effect of PTK inhibitors on the
ip/StpC-facilitated IL-2 gene expression in MOLT4 cells.
hese experiments showed that the PMA/ionomycin-
nduced increases in IL-2 secretion and mRNA level
ere significantly reduced in a concentration-dependent
ashion by genistein and herbimycin A, PTK inhibitors of
road specificity (Fig. 3A and data not shown). Likewise,
P1, an inhibitor believed to be specific for Src-family
TKs, such as Lck and Fyn (Hanke et al., 1996), de-
reased IL-2 secretion by Tip1StpC1 MOLT4 cells (Fig.
3B). Genistein, herbimycin A, and PP1 caused a de-
crease in IL-2 transcription and secretion not only in
MOLT4 cells but also in H. saimiri-transformed T cells
data not shown). Unlike PTK inhibitors, several other
otential inhibitors tested in these experiments, such as
apamycin at 100 ng/ml and wortmannin at 1 mM, did not
reduce IL-2 gene expression in MOLT 4 cells. As ex-
pected, cyclosporin A (500 ng/ml) and staurosporin (5
mM), potent inhibitors of Ca21-dependent signaling and
protein kinase C, respectively, completely abrogated IL-2
gene expression in this system (data not shown).
T4 cells were stimulated with PMA and ionomycin where indicated,
e presence of MIMIC fragments is shown for MOLT4 cells expressing
ts corresponding to IL-2 and b-actin are indicated at the top of each
ach experiment of this type, a 10-fold titration (as shown) was followedls. MOL
on in th
ragmen
ws. In eAs, and the ratios between cDNAs corresponding to IL-2 and b-actin
e experiments is shown.
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328 MERLO AND TSYGANKOVConsidering that Ras is a potential target of StpC in T
cells (see Introduction), we attempted to elucidate the
role of Ras in the observed increase in IL-2 production by
Tip1StpC1 MOLT4 cells. Tip1StpC1 MOLT4 cells were
electroporated with an expression construct encoding
FIG. 3. Effect of PTK inhibitors on IL-2 production by MOLT4 cells. (A)
wo individual clones of Tip1StpC1 MOLT4 cells were stimulated with
MA and ionomycin in the absence or in the presence of PTK inhibi-
ors, herbimycin A and genistein, at the concentrations indicated. The
mount of IL-2 in cellular supernatants was determined using ELISA.
ip1StpC1 cells did not secrete IL-2 in the absence of stimulation or in
he presence of PMA alone or ionomycin alone (see Fig. 1 and text).
riplicate measurements were performed in each experiment. Means
nd SD for one representative experiment from a total of three exper-
ments are shown. (B) Tip1StpC1 MOLT4 cells were treated with PP1
nd stimulated with PMA and ionomycin, and their supernatants were
nalyzed for IL-2 as described in (A). Means and SD for one represen-
ative experiment from a total of three experiments are shown.wild-type or inactive N17 Ras, or the corresponding
empty vector, along with the EGFP-C1 plasmid. Cells
r
sfluorescing green were selected and analyzed for IL-2
production. In these experiments, Tip1StpC1 MOLT4
cells transfected with N17 Ras showed a very high level
of N17 Ras expression, dramatically exceeding that of
endogenous Ras, but no decrease in IL-2 production as
compared to that of Tip1StpC1 cells transfected with the
empty vector (Fig. 4). It appeared impossible to compare
the effects of overexpression of N17 Ras and wild-type
Ras, because the latter caused massive cell death in our
system (data not shown).
Since the effects of Tip and StpC on MOLT4 cells were
only seen following stimulation with PMA and ionomycin,
we next examined the effects of these proteins on Jurkat
cells, which express multiple surface receptors at higher
levels than do MOLT4 cells. First, Jurkat cells simulta-
neously expressing Tip and StpC demonstrated a mod-
est, but detectable, increase in IL-2 production in re-
sponse to suboptimal concentrations of PMA and iono-
mycin over the level corresponding to vector control
Jurkat cells (data not shown). Furthermore, production of
IL-2 in response to anti-CD3 and anti-CD3 plus anti-
CD28 MAbs was significantly upregulated in Tip1StpC1
Jurkat cells. Thus, anti-CD3-induced IL-2 production was
fourfold higher in Tip1StpC1 cells than in vector control
(Tip2StpC2) cells (Fig. 5). Therefore, these experiments
demonstrated that Tip and StpC facilitated IL-2 produc-
tion not only induced by PMA and ionomycin but also
triggered by ligation of surface receptors. However, the
Tip/StpC-facilitated increase in receptor-mediated IL-2
production in Jurkat cells was significantly less profound
than the Tip/StpC-facilitated increase in PMA/ionomycin-
induced production of IL-2 in MOLT4 cells. This finding,
together with the fact that cloning efficiency of Tip1StpC1
Jurkat cells was low compared to that of Tip1StpC1
MOLT4 cells, thus preventing us from obtaining multiple
individual clones of Tip1StpC1 Jurkat and restricting our
work to the polyclonal Tip1StpC1 Jurkat cell line,
prompted us to carry out all our further experiments in
MOLT4 cells.
FIG. 4. Transient expression of wild-type and N17 Ras in Tip1StpC1
MOLT4 cells. Tip1StpC1 MOLT4 cells were electroporated in the pres-
nce of pCMV5 plasmids encoding wild-type or N17 Ras or the empty
CMV5 vector, harvested, and lysed. The lysates were loaded on a 12%
DS–PAGE as indicated at the top of the figure, separated, transferred
o nitrocellulose, and probed with anti-Ras. Protein bands were visu-
lized using chemiluminescence. A prolonged exposure revealed a
and of the endogenous Ras. The positions of a 19-kDa protein stan-
ard and Ras are shown by a horizontal bar and an arrowhead,espectively. One representative experiment from a total of two is
hown.
a329Tip AND StpC STIMULATE TRANSCRIPTIONTip and StpC upregulate activity of transcription
factors involved in IL-2 gene expression
A significant increase in the level of IL-2 mRNA in
Tip1StpC1 MOLT4 suggested that Tip and StpC might
activate IL-2 transcription. To directly assess the activity
of IL-2 promoter/enhancer in MOLT4 cells, we transiently
transfected MOLT4 cells with reporter constructs, in
which transcription of firefly luciferase was driven by the
full-length IL-2 promoter/enhancer. These experiments
FIG. 5. Effects of Tip and StpC on IL-2 secretion by Jurkat cells.
Tip1StpC1 and Tip2StpC2 (vector control) Jurkat cell lines were stim-
ulated with anti-surface receptor MAbs or a control IgG as indicated,
and their supernatants were analyzed for IL-2 using sandwich ELISA.
Triplicate measurements were performed in each experiment. Means
and SD are shown for one representative experiment from a total of two
experiments.
FIG. 6. Effects of Tip and StpC on transcriptional activity of the full-le
MOLT4 cells expressing Tip and/or StpC as indicated at the bottom of e
nd a firefly luciferase reporter construct: (A) the full-length IL-2 promo
Firefly luciferase activities were normalized using the corresponding Re
Tip2StpC2 cells was assigned the value of 1.0 for each reporter constru
of at least three independent experiments for each panel are shown. A
express firefly luciferase from the pGL3 control plasmid containing SV40 prom
capable of this expression (data not shown).demonstrated that Tip1StpC1 MOLT4 responded to
PMA/ionomycin stimulation by a substantial increase in
IL-2 promoter/enhancer-controlled luciferase production,
whereas vector control cells and cells expressing Tip or
StpC alone exhibited no increase in IL-2 promoter/en-
hancer-controlled luciferase production (Fig. 6A). This
result was consistent with the observed increase in IL-2
mRNA and protein levels in MOLT4 cells (see Figs. 1–3)
and argued that the effects of Tip and StpC on IL-2 gene
expression were directly mediated by transcription.
To elucidate the mechanisms by which Tip and StpC
upregulate transcription of the IL-2 gene, we analyzed
effects of these proteins on specific DNA response ele-
ments, AP-1, NF-AT, and NF-kB, previously determined to
be crucial for the regulation of IL-2 gene expression
(reviewed in Rothenberg and Ward, 1996; Serfling et al.,
1995). The corresponding reporter constructs were sim-
ilar to the full-length IL-2 promoter/enhancer plasmid, but
contained oligomerized individual DNA response ele-
ments fused to the minimal IL-2 promoter. The experi-
ments with these constructs showed that their transcrip-
tional activity was sensitive to extracellular stimulation
with PMA and ionomycin, although to varying extents
(Figs. 6B and 6C and data not shown). An increase in
NF-AT-controlled transcription in MOLT4 cells induced by
PMA and ionomycin was dramatically facilitated by Tip.
StpC also facilitated NF-AT-controlled transcription, but
to a lower extent. Simultaneous expression of Tip and
StpC facilitated NF-AT activation to a level comparable to
that corresponding to Tip alone (Fig. 6B).
Effects of Tip and StpC on NF-kB-controlled transcrip-
tion significantly differed from their effects on NF-AT.
First, an increase in NF-kB-controlled transcription in-
duced by PMA and ionomycin was dramatically aug-
2 promoter/enhancer and its DNA response elements in MOLT4 cells.
nel, were transfected with a Renilla luciferase internal control plasmid
ancer, (B) NF-AT, (C) NF-kB. Cells were treated as indicated and lysed.
iferase activities. Normalized firefly luciferase activity in nonstimulated
alized luciferase activities for a representative experiment from a total
ell lines used in the experiments were also examined for the ability tongth IL-
ach pa
ter/enh
nilla luc
ct. Norm
ll the coter and enhancer elements (Promega) and were found to be equally
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330 MERLO AND TSYGANKOVmented by StpC, whereas Tip exhibited only a modest
effect. Second, the simultaneous expression of Tip and
StpC facilitated NF-kB-controlled transcription to a much
higher extent than did the expression of either Tip or
StpC alone. Third, expression of StpC with or without Tip
significantly elevated NF-kB-controlled transcription in
unstimulated cells (Fig. 6C).
Unlike NF-AT and NF-kB, AP-1 showed a high level of
constitutive activity in MOLT4 cells and only a modest
further increase in response to PMA and ionomycin. No
significant differences in AP-1 activity were observed
between control cells and cells expressing Tip and/or
StpC (data not shown).
Since IL-2 gene expression in Tip1StpC1 MOLT4 was
ound to be sensitive to PTK inhibitors (see Fig. 3), we
ssessed the effect of herbimycin A on transcriptional
ctivities of all the reporter constructs utilized in our
xperiments. This analysis revealed a significant differ-
nce in sensitivities of their enhancer elements to PTK
nhibition. A PMA/ionomycin-induced increase in the
ranscriptional activity of full-length IL-2 promoter/en-
ancer or NF-kB response element was completely sup-
pressed by herbimycin, whereas those of NF-AT and
AP-1 were inhibited by less than 50% (Fig. 6 and data not
FIG. 7. Effects of Tip and StpC on NF-AT DNA-binding activity in MOLT
at the top of each panel. Their nuclear proteins were obtained and an
NF-AT binding site. Herbimycin was added to the cells as indicated at t
to binding mixtures as indicated at the top of (B). Unlabeled wild-typ
DNA–protein complexes are shown by arrowheads. Supershifted compl
three experiments for each panel is shown.shown).
To analyze the ability of Tip and StpC to activatetranscription factors involved in IL-2 gene expression
using an independent approach, we assessed binding of
MOLT4 nuclear proteins to DNA probes corresponding
to the AP-1, NF-AT, and NF-kB binding sites using EMSA.
These experiments showed that the NF-AT-specific
probe did not appreciably bind to proteins of nuclear
extracts from the vector control MOLT4 cells, either un-
stimulated or stimulated with PMA and ionomycin (Fig.
7A). However, stimulation-induced NF-AT binding was
significantly increased in MOLT4 cells expressing Tip
alone or Tip and StpC simultaneously, but not in the cells
expressing StpC alone (Fig. 7A). The NF-AT binding was
increased in Tip1StpC2 MOLT4 and Tip1StpC1 MOLT4
to a similar level, indicating, in agreement with the data
obtained using reporter constructs (see Fig. 6B), that Tip
alone was sufficient to activate NF-AT binding. A discrep-
ancy between the ability of StpC to facilitate NF-AT-
controlled expression of luciferase (Fig. 6B) and its fail-
ure to facilitate binding of proteins to a NF-AT-specific
probe (Fig. 7A) could be explained either by a higher
sensitivity of luciferase assays or by the involvement of
mechanisms unrelated to NF-AT-specific DNA–protein
binding, or by a combination of these two factors.
The observed binding to the NF-AT probe was specific,
. MOLT4 cells expressing Tip and/or StpC were stimulated as indicated
in binding assays with a 32P-labeled DNA probe corresponding to the
f (A). An anti-NF-AT antibody or normal rabbit serum (NRS) was added
or mutant (m) competitors were added at a 30-fold excess. Specific
own by an arrow. One representative experiment from a total of at least4 cells
alyzed
he top o
e (1)since it was inhibited by the identical unlabeled probe,
but not by the probe containing mutations rendering it
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331Tip AND StpC STIMULATE TRANSCRIPTIONbinding-incompetent (Fig. 7A). To further elucidate the
specificity of this binding, we performed EMSA in the
presence of anti-NF-AT and observed a supershift in the
presence of this antibody, but not in the presence of
preimmune serum (Fig. 7B). This result further argued
that NF-AT was present in the detected DNA–protein
complex. We then assessed NF-AT binding in cell lysates
from various individual MOLT4 clones and demonstrated
very similar levels of NF-AT binding in several Tip1StpC1
clones (data not shown). This experiment ruled out that
the results shown in Fig. 7 could be a consequence of
random clonal variations.
A set of similar experiments carried out to analyze
NF-kB binding showed no appreciable binding in the
ector control cells or the Tip-only cells, either stimulated
r unstimulated. In contrast, NF-kB binding was detect-
able in Tip2StpC1 MOLT4 in the absence of stimulation
and further increased following stimulation with PMA
and ionomycin (Fig. 8A). Furthermore, nuclear extracts of
Tip1StpC1 MOLT4 stimulated with PMA and ionomycin
howed a significant increase in NF-kB binding activity
compared to those of Tip2StpC1 MOLT4 (Fig. 8A). There-
FIG. 8. Effects of Tip and StpC on NF-kB DNA-binding activity in MOLT
at the top of each panel. Their nuclear proteins were obtained and an
NF-kB binding site. Herbimycin was added to the cells as indicated at
a long and a short exposure of the same gel. Antibodies to NF-kB prote
at the top of (B). Unlabeled wild-type (1) or mutant (m) competitors we
arrowheads. Supershifted complexes are shown by asterisks. One repre
is shown.ore, the findings of EMSA experiments with the NF-kB
robe were consistent with the results obtained usingthe NF-kB reporter construct, except that an increase in
NF-kB transcriptional activity in MOLT4 cells expressing
Tip alone was detected using luciferase reporter assays
(Fig. 6C), but not EMSA (Fig. 8A). This finding, like that for
NF-AT, could be explained either by a higher sensitivity of
reporter assays or by the involvement of mechanisms
unrelated to specific DNA–protein binding to the ob-
served increase in reporter activity, or by a combination
of both factors.
Specificity of NF-kB binding was confirmed using un-
labeled wild-type and mutated NF-kB probes (Fig. 8). To
further characterize specificity of the observed interac-
tions, we carried out supershift experiments using the
approach described above for NF-AT. These experiments
identified p50 and p65 as components of the NF-kB
complex in Tip1StpC1 MOLT4 cells (Fig. 8B). To rule out
the possibility that the results shown in Fig. 8 were a
consequence of random differences between individual
clones, we assessed levels of NF-kB binding in several
Tip1StpC1 MOLT4 clones and found these levels to be
very similar (data not shown).
AP-1 binding activity of MOLT4 nuclear proteins was
. MOLT4 cells expressing Tip and/or StpC were stimulated as indicated
in binding assays with a 32P-labeled DNA probe corresponding to the
of (A). The top and the bottom panels in (A) demonstrate, respectively,
ormal rabbit serum (NRS) were added to binding mixtures as indicated
d at a 30-fold excess. Specific DNA–protein complexes are shown by
ive experiment from a total of at least three experiments for each panel4 cells
alyzed
the top
ins or n
re addedetectable in nonstimulated cells and remained essen-
tially unaffected by expression of Tip and StpC (data not
t
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obtained using the AP-1 reporter construct (see above).
The failure of Tip and StpC to affect AP-1 binding to-
gether with a high level of AP-1 binding in nonstimulated
MOLT4 cells argue against a substantial involvement of
AP-1 in mediating the observed effects of Tip and StpC
on IL-2 gene expression.
The results of EMSA experiments demonstrated, in
agreement with the data obtained using reporter con-
structs, that herbimycin A did not inhibit either NF-AT or
AP-1 binding in MOLT4 cells (Fig. 7A and data not
shown). In contrast, NF-kB binding was dramatically in-
hibited by herbimycin A in both StpC1 MOLT4 and
Tip1StpC1 MOLT4 cells (Fig. 8A). This finding is consis-
ent with the corresponding reporter construct results
see Fig. 6), indicating that the effect of Tip and StpC on
F-kB activity is PTK-dependent.
Since the level of IL-2 mRNA is also affected by the life
pan of IL-2-producing T cells, the observed effect of Tip
nd StpC on IL-2 gene expression may be mediated, at
east in part, by their antiapoptotic effect on MOLT4 cells.
o address this issue, we examined the effect of simul-
aneous expression of Tip and StpC on viability and
poptosis of MOLT4 cells. These experiments showed
hat the number of viable cells was somewhat decreased
n cultures of Tip1StpC1 MOLT4 cells compared to those
f Tip2StpC2 vector control cells, whereas the amount of
cytoplasmic DNA–histone complexes indicative of apo-
ptosis was slightly increased in Tip1StpC1 MOLT4 cells
compared to that in vector control cells (data not shown).
These results indicated that an increase in IL-2 gene
expression caused by Tip and StpC was not mediated by
an increase in T-cell resistance to stimulation-induced
apoptosis. This result was consistent with a report indi-
cating that H. saimiri-induced transformation did not in-
crease resistance of T cells to apoptosis (Kraft et al.,
1998).
DISCUSSION
Despite the established role of Tip and StpC in H.
saimiri-induced T-cell transformation, little is known
about the molecular mechanisms of their effects. This is,
at least in part, the result of difficulties in separating the
partial effects of Tip and StpC in H. saimiri-transformed T
cells. Furthermore, it is important to separate the effects
of Tip and StpC on T cells from possible effects of other
H. saimiri gene products, such as a IL-17-like cytokine
(Fossiez et al., 1996), a homolog of the IL-8 receptor
(Albrecht et al., 1992; Yao et al., 1995), regulators of gene
expression (Nicholas et al., 1988; Whitehouse et al.,
1998a,b), a homolog of the mouse mammary tumor virus
superantigen (Albrecht et al., 1992; Knappe et al., 1997),
a cyclin D3 homolog (Albrecht et al., 1992; Jung et al.,
1994), and a bcl-2 homolog (Derfuss et al., 1998; Nava et
al., 1997). Although constitutive expression of genesother than tip and stpC in H. saimiri-transformed human
T cells has not been shown, their effects on T cells
cannot be ruled out. Therefore, we chose expression of
isolated Tip and/or StpC cDNAs in lymphoblastoid cells
as an experimental system in which effects of Tip and
StpC can be separated from each other, as well as from
the effects of other H. saimiri proteins. Although this
system does not allow for assessing the ability of Tip and
StpC to transform T cells, this shortcoming is compen-
sated by its advantages for analyzing effects of Tip and
StpC on signal transduction and gene expression, the
deciphering of which is crucial for the understanding of
interactions between H. saimiri and cells transformed by
this virus.
Although it was previously shown that both Tip and
StpC are essential for H. saimiri-induced transformation
(Duboise et al., 1998; Medveczky et al., 1993), the molec-
ular basis of the effects of Tip and StpC on T-cell re-
sponses remains poorly understood. In this report, we
demonstrate that simultaneous expression of Tip and
StpC in Jurkat and MOLT4 cells significantly facilitates
IL-2 gene expression induced by extracellular stimula-
tion (Figs. 1–3, 5). Our results indicate that the effect of
the simultaneous expression of Tip and StpC on IL-2
production in Jurkat cells is substantially less profound
than this effect in MOLT4 cells. Although the reasons for
this disparity are not entirely clear, the difference in the
levels of stimulation-induced IL-2 production between
wild-type Jurkat cells and MOLT4 cells may play a role
(Figs. 1 and 5); the low level of IL-2 production by MOLT4
cells may highlight the effect of Tip and StpC, whereas
the high level of IL-2 production by Jurkat cells may mask
these effects.
The results presented in our report identify the IL-2
gene as a target for the cooperative effect of Tip and
StpC, independent of any other H. saimiri proteins. This
effect of Tip and StpC is clearly synergistic, since neither
Tip nor StpC alone is able to facilitate IL-2 production
(Fig. 1). Our results are consistent with the previously
published data that human T cells infected with wild-type
H. saimiri, but not with H. saimiri-deletion mutants lack-
ing either Tip or StpC, upregulate expression of the IL-2
gene (Chou et al., 1995). The synergism between Tip and
StpC observed in our study appears to be the result of
the differential enhancement of transcription factor activ-
ity by these proteins. Tip alone is capable of activating
NF-AT in MOLT4 cells to a significantly higher extent than
is StpC alone (Figs. 6B and 7). By contrast, StpC alone
can activate NF-kB in these cells to a much higher extent
than can Tip alone (Figs. 6C and 8). Since both NF-AT
and NF-kB should be activated to upregulate IL-2 gene
transcription (reviewed in Rothenberg and Ward, 1996;
Serfling et al., 1995), it is apparent that both Tip and StpC
are required to cause the observed dramatic increase in
IL-2 gene expression in the T cells studied. Furthermore,
we showed that profound synergism between Tip and
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333Tip AND StpC STIMULATE TRANSCRIPTIONStpC also exists at the level of activation of a single
transcription factor, NF-kB. Although Tip alone activates
NF-kB to a very modest extent, it significantly enhances
he StpC-induced activation of NF-kB (Figs. 6C and 8).
This effect is likely to be another reason for the syner-
gism between Tip and StpC in upregulating IL-2 gene
expression.
AP-1 activity remains unaffected by either Tip or StpC.
The failure of Tip and StpC to facilitate AP-1 activation
appears to be irrelevant to the observed increase in IL-2
gene expression, since constitutive AP-1 activity in
MOLT4 cells is high and can be increased further by
PMA and ionomycin, albeit to a modest extent, regard-
less of the presence of Tip or StpC. It remains to be
elucidated whether transcription factors other than NF-
AT, NF-kB, and AP-1, such as EGR-1 (Skerka et al., 1995),
play a role in the effects of Tip and StpC on IL-2 gene
expression.
It was recently shown that, through its ability to inter-
act with Stat transcription factors, Tip causes an in-
crease in Stat-dependent transcription in Jurkat cells
expressing the SV-40 large T antigen, including a twofold
increase in c-fos transcription (Hartley and Cooper,
000). This Tip-facilitated increase in Stat activity is likely
o contribute to the overall effect of Tip on T cells. It may
lso contribute to the activation of NF-AT in our system
hat is induced by Tip in a StpC-independent fashion,
ince c-Fos is a functional component of the NF-AT
ranscription complex (reviewed in Rao, 1994). However,
he Tip-mediated activation of Stat may not exert a direct
ffect on IL-2 promoter/enhancer, which lacks Stat-spe-
ific response elements (reviewed in Rothenberg and
ard, 1996; Serfling et al., 1995). Moreover, the effect of
Tip and StpC on NF-kB described in our study is most
likely independent of Stat activity, since no direct con-
nection between these systems of transcriptional regu-
lation has yet been established. Another recent report
indicates that expression of StpC in an epithelial cell line
modestly stimulates NF-kB, as shown using a NF-kB-
sensitive reporter construct (Lee et al., 1999). Besides
hese findings, little is known about the effects of Tip and
tpC on transcription. In particular, no information is
vailable regarding interactions of Tip and StpC at the
evel of transcriptional regulation and gene expression.
ur report is the first demonstration of a profound syn-
rgistic effect of Tip and StpC on DNA binding and
ranscriptional activity of NF-kB, as well as IL-2 transcrip-
tion, in cells expressing these viral oncoproteins in the
absence of other H. saimiri proteins.
The synergistic activation of NF-kB by Tip and StpC in
MOLT4 cells appears to be significantly reduced by her-
bimycin A, a potent inhibitor of PTKs (Figs. 6C and 8).
Therefore, the effect of Tip and StpC on NF-kB is, at least
partially, dependent on PTK activity. This conclusion is in
agreement with the ability of PTK inhibitors, including
PP1, which is specific for Src-family PTKs, to reduceTip/StpC-facilitated IL-2 gene expression and IL-2 pro-
moter/enhancer activity (Figs. 3 and 6A). Inhibition of IL-2
production by PP1 (Fig. 3B) argues that Lck may be
involved in the observed effects of Tip and StpC on
MOLT4 cells. This notion is consistent with observations
made in multiple experimental systems that the kinase
activity of Lck and tyrosine phosphorylation of cellular
protein is increased in cells expressing Tip and that the
activity of Lck is elevated when this PTK interacts with
Tip in vitro (Hartley et al., 1999; Lund et al., 1997b; Wiese
et al., 1996). Considering these results, downregulation
of Lck activity in Jurkat cells that were transduced with a
retroviral vector to express Tip (Guo et al., 1997; Jung et
al., 1995) is unlikely to be an immediate result of the
interactions between Tip and Lck but, rather, is a conse-
quence of the negative feedback mechanism, which pre-
vents hyperactivation of Lck, an important regulatory
PTK. It is unclear whether such a mechanism is engaged
in H. saimiri-transformed cells, although the apparent
lack of significant downregulation of Lck in human T
cells transformed by H. saimiri (Biesinger et al., 1995;
Lund et al., 1997b; Wiese et al., 1996) argues against this
ypothesis.
However, PP1 shows no absolute specificity for Lck
Hanke et al., 1996), and the observed inhibition of IL-2
roduction by PP1 appears to be incomplete (Fig. 3B).
herefore, participation of PTKs other than Lck in the
bserved effects of Tip and StpC cannot be ruled out.
ur results, demonstrating that T-cell responses to PMA
nd ionomycin facilitated by Tip and StpC are PTK-de-
endent, suggest that crucial tyrosine phosphorylation
argets are located either downstream of targets of PMA
nd ionomycin or in PMA/ionomycin-insensitive signal-
ng pathways. The nature of these targets and the mech-
nisms by which Tip increases their tyrosine phosphor-
lation in MOLT4 and Jurkat cells remains to be eluci-
ated further. It is possible that PTKs acting downstream
f phosphatydilinositol-39 kinase and phospholipase Cg
(August et al., 1997; Lev et al., 1995; Li et al., 1997;
Okazaki et al., 1997) may be involved in the effects of Tip
and StpC. It remains intriguing and unclear why, despite
the importance of protein tyrosine phosphorylation for
the overall effect of Tip and StpC on IL-2 production, the
effect of Tip on NF-AT activation in MOLT4 cells was
shown to be insensitive to PTK inhibitors (Figs. 6B and 8).
This result indicates that Tip activates NF-AT in a PTK-
independent fashion, thus requiring further investigation.
The notion that the synergistic effect of Tip and StpC
on NF-kB activity and, ultimately, on IL-2 production is
likely to be mediated by signaling molecules that are
located well downstream in signal transduction path-
ways is further supported by our current results, demon-
strating that dominant-negative Ras does not inhibit IL-2
production increased by Tip and StpC. Therefore, the
ability of StpC to bind to and activate Ras (Jung and
Desrosiers, 1995) is unlikely to be related to the contri-
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experimental system. Thus, molecular targets of StpC
and mechanisms by which it participates in the observed
upregulation of IL-2 production remain to be elucidated.
Overall, the observed effects of Tip and StpC on cel-
lular signaling and gene expression in MOLT4 cells
agree with the idea that a critical role is played by these
proteins in H. saimiri-induced transformation. Indeed, it
was previously shown that IL-2 promotes TCR-indepen-
dent growth of H. saimiri-transformed T cells in an auto-
rine fashion (Broker et al., 1994; De Carli et al., 1993;
ittrucker et al., 1992, 1993). TCR-independent produc-
ion of IL-2 by H. saimiri-transformed T cells appears to
be triggered by the constant CD2-mediated stimulation
of these cells induced by cell–cell contacts (De Carli et
al., 1993; Fickenscher et al., 1997; Mittrucker et al., 1992;
Weber et al., 1993). Supporting this notion, the effects of
Tip and StpC on IL-2 gene expression in MOLT4 cells are
stimulation-dependent.
It should be noted, however, that the T-cell systems
used in this study have certain limitations resulting from
the lack of expression of H. saimiri genes other than tip
and stpC. Although the activation of transcription factors
and IL-2 gene expression by Tip and StpC observed in
MOLT4 and Jurkat cells is likely to mirror the effects of
these H. saimiri proteins on multiple types of T cells,
these findings are unlikely to fully describe the contribu-
tion of Tip and StpC to the biology of H. saimiri, in which
the interactions of Tip and StpC with other H. saimiri
proteins are likely to be important.
Finally, the observed effects of Tip and StpC on tran-
scription factors are likely to affect multiple genes. For
example, it was recently shown that Tip and StpC dra-
matically affect HIV replication in MOLT4 cells (Hender-
son et al., 1999). Therefore, Tip and StpC may be inter-
esting not only for their role in H. saimiri-induced trans-
formation, but also as potential modifiers of various T-cell
responses.
MATERIALS AND METHODS
Plasmids and transfection
The pCRII and MSCV vectors containing cDNAs of Tip
and StpC were described previously (Merlo et al., 1998).
Wild-type Ras and its N17 inactive form were expressed
using pCMV5-based vectors (kindly provided by Dr. D.
Dhanasekaran, Temple University, Philadelphia, PA).
Cells were cotransfected, where indicated, with an ex-
pression plasmid encoding green fluorescent protein
(EGFP-C1; Clontech, Palo Alto, CA). Expression plasmids
were transfected into T cells using electroporation in 500
ml of 2 3 107/ml cell suspension in the Opti-MEM me-
dium (Gibco/BRL, Grand Island, NY) at 250 V, 950 mF, in
the presence of 50 mg expression vector.Cell lines and clones
Human MOLT4 and Jurkat lymphoblastoid T cells and
hybridomas producing MAbs to CD2, CD3, CD4, and
CD8 (OKT11, OKT3, OKT4, and OKT8, respectively) were
obtained from ATCC (Rockville, MD). MOLT4 and Jurkat
cells were transduced to express Tip and/or StpC by
retroviral gene transfer as described previously (Merlo et
l., 1998). Cells transduced with the puromycin N-acetyl-
transferase gene (pac)-containing vectors were selected
using puromycin (Sigma, St. Louis, MO). Cells trans-
duced with the neomycin phosphotransferase gene
(neo)-containing vectors were selected with G418 (Medi-
atech, Herndon, VA). The clones were generated by lim-
iting dilution and then analyzed for integration of the
corresponding cDNAs into their genomic DNA and for
the presence of protein products of tip and stpC as
described previously (Merlo et al., 1998). Multiple indi-
idual clones of transduced MOLT4 cells were used.
olyclonal cell lines of transduced Jurkat cells were uti-
ized, since few individual clones of transduced Jurkat
ells were generated. T cells were grown in RPMI 1640
edium supplemented with 10% fetal bovine serum, L-
glutamine, antibiotics, and HEPES (Gibco/BRL), as well
as puromycin and/or G418 where indicated. Where indi-
cated, cells were analyzed or sorted using an EPICS flow
cytometer (Coulter, Fullerton, CA). Cells were stained for
flow cytometry with MAbs to CD2, CD3, CD4, CD8, or
CD28 described in the previous section followed by
FITC-labeled goat anti-mouse IgG (Cappel, Durham, NC)
using protocols described previously (Tsygankov et al.,
1992).
Activation of cells
T cells were harvested and resuspended in RPMI 1640
supplemented with 20 mM HEPES at a density of either
2 3 107/ml or 1 3 106/ml for biochemical and gene
expression experiments, respectively, unless indicated
otherwise. To study IL-2 transcription and transcription
factor activity, cells were stimulated with PMA and iono-
mycin (both from Sigma) at final concentrations of 50
ng/ml and 1 mM, respectively, at 37°C for 4 h. To study
IL-2 secretion, cells were stimulated under the same
conditions, but supernatants were collected at 12 h after
stimulation unless indicated otherwise. To study IL-2
production in response to stimulation through surface
receptors, cells were incubated in culture plates coated
with anti-receptor MAbs. The plates were precoated with
goat anti-mouse IgG (Cappel) at a concentration of 10
mg/ml overnight and then coated with appropriate MAbs
at 1 mg/ml for 2 h. The OKT3, OKT4, OKT8, and OKT11
MAbs were prepared from hybridoma supernatants us-
ing protein A–Sepharose (Amersham Pharmacia Biotech,
Piscataway, NJ) according to the manufacturer’s protocol.
Anti-CD28 MAb was purchased from Pharmingen (San
Diego, CA). Genistein or herbimycin A (both from BioMol
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335Tip AND StpC STIMULATE TRANSCRIPTIONResearch Laboratories, Plymouth Meeting, PA) was
added 15 min or 15 h prior to stimulation, respectively.
Staurosporin, cyclosporin A, rapamycin, and PP1 (all
from BioMol Research Laboratories) and wortmannin
(Alexis, San Diego, CA) were added 30 min prior to
stimulation.
Preparation of RNA and cDNA
Total RNA was isolated from T cells using the RNAzol
B reagent (Tel-Test, Friendswood, TX) according to the
manufacturer’s recommendations. Briefly, cells were
mixed first with RNAzol and then with chloroform. The
samples were centrifuged at 12,000 g for 15 min at 4°C
and the aqueous layers containing RNA were collected.
RNA was precipitated with isopropanol and then washed
with ethanol. The obtained RNA was denatured at 75°C
and a 5-mg aliquot was added to the reaction mixture
containing 10–20 units avian myeloblastosis virus re-
verse transcriptase (Promega, Madison, WI), 0.5 mg oligo
dT (Promega), dNTPs (each at 1 mM; Gibco/BRL), 10
units RNase inhibitor (Promega), and buffer (50 mM Tris–
HCl, pH 8.3; 50 mM KCl; 10 mM MgCl2; 0.5 mM spermi-
ine; 10 mM DTT). The reaction mixture was incubated at
2°C for 1 h and then inactivated at 75°C for 10 min.
uantitation of specific cDNA
Concentrations of lymphokine-specific cDNAs were
etermined using a quantitative PCR analysis with com-
etitor, or MIMIC, fragments essentially as described in
i et al. (1991) and Strehlau et al. (1997). MIMIC frag-
ents were heterologous to cDNAs of interest, but con-
ained flanking sequences complementary to the primers
pecific for these DNAs. Therefore, MIMICs competed
ith the DNAs of interest for specific primers acting as
nternal standards in PCR reactions. The MIMIC frag-
ents were obtained using the PCR MIMIC Construction
it (Clontech). Composite primers (The Great American
ene Company, Ramona, CA) containing sequences
omplementary to both a nonhomologous internal stan-
ard (the BamHI/EcoRI fragment of v-erbB cDNA) and the
DNAs of interest (IL-2, b-actin) were used to amplify this
nonhomologous competitor fragment and to introduce
flanking lymphokine cDNA sequences to the resulting
chimeric DNA molecule. For b-actin, the composite prim-
ers were 59-GTG GGG CGC CCC AGG CAC CAC GCA
AGT GAA ATC TCC TCC G-39 and 59-CTC CTT AAT GTC
ACG CAC GAT TTC GGG ACA AGA TAC TCA TCT GC-39.
For IL-2, the composite primers were 59-ACT CAC CAG
GAT GCT CAC ATC GCA AGT GAA ATC TCC TCC G-39
and 59-AGG TAA TCC ATC TGT TCA GAT TGA GTC CAT
GGG GAG CTT T-39 (in both cases v-erbB-specific se-
quences are underlined). For b-actin, the transcript-spe-
cific primers were 59-GTG GGG CGC CCC AGG CAC
CA-39 and 59-CTC CTT AAT GTC ACG CAC GAT TTC-39.
c
iFor IL-2, they were 59-ACT CAC CAG GAT GCT CAC AT-39
and 59-AGG TAA TCC ATC TGT TCA GA-39.
The concentrations of the competitors were deter-
mined using spectrophotometry and verified by gel elec-
trophoresis. Appropriate dilutions of MIMICs were then
prepared for use in competitive PCR reactions. To deter-
mine the concentration of a specific cDNA, a series of
competitive PCR reactions was performed for this cDNA
at a constant concentration of the total sample cDNA
(0.05 mg/sample) and varying concentrations of the cor-
responding MIMIC. The amplification products corre-
sponding to the cDNA of interest and the MIMIC were
analyzed using agarose gel electrophoresis and identi-
fied according to their characteristic sizes: 266 bp for
IL-2, 600 bp for IL-2 MIMIC, 548 bp for b-actin, 420 bp for
b-actin MIMIC. The ratio between the two products var-
ied, mirroring the changes in the MIMIC concentration.
The molar concentration of the cDNA of interest was
determined to be equal to the MIMIC concentration at
the point of equal intensity of the cDNA band and the
MIMIC band. In addition to the sample DNA and MIMIC,
the reaction mixture contained 0.5 unit Taq DNA poly-
erase (Promega), oligonucleotide primers specific for
he cDNA of interest (0.5 mM each; The Great American
Gene Company), dNTPs (0.2 mM each), 1.5 mM MgCl2,
and PCR buffer (Promega) in a total volume of 25 ml. The
mount of lymphokine-specific cDNAs was normalized
o the amount of cDNA for a housekeeping gene, b-actin.
The b-actin cDNA was quantified in every sample, and
the molar ratios of lymphokine-specific cDNAs to the
b-actin cDNA were determined.
Enzyme-linked immunoadsorbent assays (ELISA)
Concentration of secreted IL-2 was measured by
sandwich ELISA using capture and detection antibodies
from Pharmingen following the manufacturer’s recom-
mendations. Briefly, wells of 96-well plates were coated
with a capture antibody (rat IgG2a anti-human IL-2 MAb)
and then blocked with 1% BSA in PBS. Supernatant
samples and IL-2 standards (Eurocetus, Amsterdam, The
Netherlands) were diluted with blocking buffer, added to
the wells, and incubated at room temperature for 3 h. The
plates were then washed, and a biotinylated detection
antibody (mouse IgG1 MAb to human IL-2) was added for
1 h. Streptavidin-conjugated horseradish peroxidase
(Vector Laboratories, Burlingame, CA) followed by hydro-
gen peroxide and the chromogenic peroxidase substrate
2,29-azinibis(3-ethylbenzthiazoline-sulfonic acid) (Sigma)
ere added to visualize the detection antibody. Enzy-
atic reactions were stopped with dimethylformamide
nd SDS, and the product was measured at 405 nm
sing a Vmax Kinetic Microplate Reader (Molecular De-
ices, Sunnyvale, CA). The presence of DNA/histone
omplexes in cytoplasmic cell lysates was analyzed us-
ng a similar ELISA assay using a capture mouse anti-
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336 MERLO AND TSYGANKOVhistone H2B MAb and a detection mouse anti-nucleo-
some MAb as described in Salgame et al. (1997).
lectrophoretic mobility shift assays (EMSA)
Extraction of nuclear proteins for EMSA was per-
ormed as described in Schreiber et al. (1989). Briefly,
ells were harvested, washed, and kept in buffer con-
aining 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA,
.1 mM EGTA, 1 mM DTT, and 0.5 mM PMSF on ice for 15
in to swell. NP-40 was then added to the samples to a
inal concentration of 0.5% to lyse the cells. Following
entrifugation at 13,000 g for 15 s at 4°C, the resultant
uclear pellets were extracted with the buffer containing
0 mM HEPES (pH 7.9), 0.4 mM NaCl, 1 mM EDTA, 1 mM
GTA, 1 mM DTT, and 1 mM PMSF. To detect electro-
horetic mobility shifts, oligonucleotides corresponding
o the consensus NF-kB and AP-1 DNA response ele-
ments (59-AGT TGA GGG GAC TTT CCC AGG C-39 and
59-CGC TTG ATG AGT CAG CCG GAA-39, respectively)
and the distal NF-AT site of the human IL-2 promoter/
enhancer (59-CAT GAA ACA GTT TTT CCT CCT TA-39)
along with their mutant forms incapable of binding tran-
scription factors were used (59-AGT TGA GGC GAC TTT
CCC AGG C-39, 59-CGC TTG ATG AGT TGG CCG GAA-39,
59-TAA GGC TTC CAA ACT GTT TCA TG-39, respectively).
(Mutated nucleotides are underlined; only one strand is
shown for each probe.) Oligonucleotides were 32P-la-
beled using T4 polynucleotide kinase (Promega) in the
presence of 10 mCi [g-32P]ATP (7000 Ci/mmol; ICN, Irvine,
CA). The labeled probes were separated from [g-32P]ATP
sing Pharmacia Microspin columns. The final concen-
ration and radioactivity of probes was 0.5 ng/ml and 2 3
108 cpm/ml, respectively. Binding was carried out in
0-ml samples containing equal amounts of total nuclear
protein (1–3 mg), 0.5 ng 32P-radiolabeled probe, and 1g
poly(dIdC) (Sigma). NF-AT binding assays were carried
out in 10 mM Tris (pH 7.5), 50 mM NaCl, 1 mM EDTA, 5%
glycerol, and 1 mM DTT. NF-kB binding assays were
carried out in 20 mM Tris (pH 7.5), 60 mM KCl, 2 mM
EDTA, 4% Ficoll, and 1 mM DTT. AP-1 binding buffer was
the same as that for NF-kB plus 5 mM MgCl2. The
binding samples were incubated at room temperature for
30 min and separated on a 5% polyacrylamide gel. The
gels were dried and probes were visualized by autora-
diography. For supershift assays the reactions were car-
ried out in the presence of 2 mg/sample antibodies to the
respective transcription factors (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) added 30 min prior to labeled probe.
Luciferase reporter assays
To directly assess the activity of IL-2 promoter/en-
hancer and that of its DNA response elements, we uti-
lized the reporter constructs in which regulatory DNA
sequences were inserted upstream of the firefly lucif-
erase gene in pGL3 basic vector (Promega). pIL-2/GL3contained the nucleotides 2326 to 145 of human IL-2
romoter/enhancer. In other reporter plasmids oligomer-
zed binding sites for transcription factors were inserted
nto the minimal IL-2 promoter (nucleotides 2326 to
294 and 277 to 145). pAP-1/GL3, pNF-AT/GL3, and
NF-kB/GL3 contained, respectively, five copies of the
metallothionein promoter AP-1 site, three copies of the
distal human IL-2 promoter NF-AT site, and three copies
of the Igk chain enhancer NF-kB site. The constructs
were kindly provided by Drs. G. Crabtree (Stanford Uni-
versity) and S. Ho (University of California–San Diego).
The pRL-0 vector (Promega) encoding luciferase from
Renilla reniformis but lacking any eukaryotic promoter
was used as an internal control to normalize the expres-
sion of firefly luciferase for transfection efficiency (Behre
et al., 1999). Cells were electroporated in 500 ml of 2 3
107/ml cell suspension in the Opti-MEM medium (Gibco/
BRL) at 250 V, 950 mF, in the presence of a reporter
construct (50 mg) and the pRL-0 internal control (3 mg).
Cells were activated as described above, harvested, and
lysed in Passive Lysis Buffer (Promega). Luciferase ac-
tivity was measured in the lysates using a Dual-Lucif-
erase Assay System (Promega).
Immunoblotting
Immunoblotting methods were described previously
(Biesinger et al., 1995; Broker et al., 1993, 1994; Wiese et
al., 1996). Briefly, whole cell lysates were treated with
SDS–PAGE sample buffer. Then proteins of these lysates
or immunoprecipitates were separated by SDS–PAGE
and transferred to nitrocellulose (Bio-Rad Laboratories,
Richmond, CA), which was then probed with the 238
anti-Ras MAb (Santa Cruz Biotechnology) in blocking
buffer. Then protein bands were visualized by enhanced
chemiluminescence using an ECL Plus kit (Amersham
Pharmacia Biotech).
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